Search

Your search keyword '"Chauhan, Cynthia"' showing total 49 results
Start Over Author "Chauhan, Cynthia"
49 results on '"Chauhan, Cynthia"'

2. Cardio-Oncology and Heart Failure: a Scientific Statement From the Heart Failure Society of America

Author

BLOOM, MICHELLE WEISFELNER, VO, JACQUELINE B., RODGERS, JO E., FERRARI, ALANA M., NOHRIA, ANJU, DESWAL, ANITA, CHENG, RICHARD K., KITTLESON, MICHELLE M., UPSHAW, JENICA N., PALASKAS, NICOLAS, BLAES, ANNE, BROWN, SHERRY-ANN, KY, BONNIE, LENIHAN, DANIEL, MAURER, MATHEW S., FADOL, ANECITA, SKURKA, KERRY, CAMBARERI, CHRISTINE, CHAUHAN, CYNTHIA, and BARAC, ANA

Published
2025
Full Text
View/download PDF

6. Palliative Care for Patients With Cancer: ASCO Guideline Update

Author

Sanders, Justin J., primary, Temin, Sarah, additional, Ghoshal, Arun, additional, Alesi, Erin R., additional, Ali, Zipporah Vunoro, additional, Chauhan, Cynthia, additional, Cleary, James F., additional, Epstein, Andrew S., additional, Firn, Janice I., additional, Jones, Joshua A., additional, Litzow, Mark R., additional, Lundquist, Debra, additional, Mardones, Mabel Alejandra, additional, Nipp, Ryan David, additional, Rabow, Michael W., additional, Rosa, William E., additional, Zimmermann, Camilla, additional, and Ferrell, Betty R., additional

Published
2024
Full Text
View/download PDF

8. Advocate-BREAST: advocates and patients' advice to enhance breast cancer care delivery, patient experience and patient centered research by 2025.

Author

O'Sullivan, Ciara C., Larson, Nicole L., Vierkant, Robert A., Smith, Mary Lou, Chauhan, Cynthia, Couch, Fergus J., Olson, Janet E., Loprinzi, Charles L., and Ruddy, Kathryn J.

Subjects
METASTATIC breast cancer, PATIENT experience, PATIENTS' attitudes, BREAST cancer, HOT flashes
Abstract

Purpose: The aims of the Advocate-BREAST project are to study and improve the breast cancer (BC) patient experience through education and patient-centered research. Methods: In December 2021, an electronic REDCap survey was circulated to 6,918 BC survivors (stage 0–4) enrolled in the Mayo Clinic Breast Disease Registry. The questionnaire asked about satisfaction with BC care delivery, and education and support receive(d) regarding BC linked concerns. Patients also ranked Quality Improvement (QI) proposals. Results: The survey received 2,437 responses. 18% had Ductal Carcinoma in Situ, 81% had early breast cancer (EBC), i.e. stage 1–3, and 2% had metastatic breast cancer (MBC). Mean age was 64 (SD 11.8), and mean time since diagnosis was 93 months (SD 70.2). 69.3% of patients received all care at Mayo Clinic. The overall experience of care was good (> 90%). The main severe symptoms recalled in year 1 were alopecia, eyebrow/eyelash thinning, hot flashes, sexual dysfunction, and cognitive issues. The main concerns recalled were fear of BC recurrence/spread; loved ones coping; fear of dying, and emotional health. Patients were most dissatisfied with information regarding sexual dysfunction, eyebrow/eyelash thinning, peripheral neuropathy, and on side effects of immunotherapy/targeted therapies. Top ranking QI projects were: i) Lifetime access to concise educational resources; ii) Holistic support programs for MBC and iii) Wellness Programs for EBC and MBC. Conclusions: Patients with early and advanced BC desire psychological support, concise educational resources, and holistic care. Implications: Focused research and QI initiatives in these areas will improve the BC patient experience. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

9. Advocate-BREAST80+: A Comprehensive Patient and Advocate-Led Study to Enhance Breast Cancer Care Delivery and Patient-Centered Research in Women Aged ≥80 Years.

Author

O'Sullivan, Ciara C., Vierkant, Robert A., Larson, Nicole L., Smith, Mary Lou, Chauhan, Cynthia, Couch, Fergus J., Olson, Janet E., D'Andre, Stacy, Jatoi, Aminah, and Ruddy, Kathryn J.

Subjects
BREAST tumor treatment, PATIENT education, PSYCHOLOGICAL distress, RESEARCH funding, BREAST tumors, CLINICAL medicine research, MEDICAL care, INTERVIEWING, DECISION making, DESCRIPTIVE statistics, CANCER patients, SYMPTOMS, PATIENT-centered care, SURVEYS, WOMEN'S health, NEEDS assessment, PATIENT satisfaction, SELF advocacy
Abstract

Simple Summary: The high-level aims of the Advocate-BREAST initiative are to study and improve the overall experience of patients with breast cancer (BC) through education, shared decision making, and patient-centered clinical trials. Advocate-BREAST80+ is a survey substudy that specifically focused on the unique needs and perspectives of BC patients aged ≥80 years. Although patients aged ≥80 years experienced less anxiety and symptom-related distress compared with younger patients, they were significantly less satisfied with information regarding short and long term side effects of BC therapies, as well as the management of same. Older patients were significantly less likely to have participated in a clinical trial or be open to considering this option in future. Future research should address unique educational needs and barriers to research participation in older BC patients. Focused interviews could assist with better comprehension of the lived experience of these patients, given the smaller number of BC patients ≥80 years in many available databases. Background: There are limited evidence-based data to guide treatment recommendations for breast cancer (BC) patients ≥80 years (P80+). Identifying and addressing unmet needs are critical. Aims: Advocate-BREAST80+ compared the needs of P80+ vs. patients < 80 years (P80−). Methods: In 12/2021, a REDCap survey was electronically circulated to 6918 persons enrolled in the Mayo Clinic Breast Disease Registry. The survey asked about concerns and satisfaction with multiple aspects of BC care. Results: Overall, 2437 participants responded (35% response rate); 202 (8.3%) were P80+. P80+ were less likely to undergo local regional and systemic therapies vs. P80− (p < 0.01). Notably, P80+ were significantly less satisfied with information about the short and long-term side effects of BC therapies and managing toxicities. P80+ were also less likely to have participated in a clinical trial (p < 0.001) or to want to do so in the future (p = 0.0001). Conclusions: Although P80+ experienced less anxiety and symptom-related distress compared with P80−, they were significantly less satisfied with information regarding the side effects of BC therapies and their management. P80+ were significantly less likely to have participated in a clinical trial or be open to considering this option. Future studies should address educational needs pertaining to side effects and barriers to research participation in P80+. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

12. Advancing Research on the Complex Interrelations Between Atrial Fibrillation and Heart Failure: A Report From a US National Heart, Lung, and Blood Institute Virtual Workshop

Author

Al-Khatib, Sana M., Benjamin, Emelia J., Albert, Christine M., Alonso, Alvaro, Chauhan, Cynthia, Chen, Peng-Sheng, Curtis, Anne B., Desvigne-Nickens, Patrice, Ho, Jennifer E., Lam, Carolyn S.P., Link, Mark S., Patton, Kristen K., Redfield, Margaret M., Rienstra, Michiel, Rosenberg, Yves, Schnabel, Renate, Spertus, John A., Stevenson, Lynne Warner, Hills, Mellanie True, Voors, Adriaan A., Cooper, Lawton S., and Go, Alan S.

Published
2020
Full Text
View/download PDF

15. The Establishment of the GENEQOL Consortium to Investigate the Genetic Disposition of Patient-reported Quality-of-life Outcomes

Author

Sprangers, Mirjam AG, Sloan, Jeff A, Veenhoven, Ruut, Cleeland, Charles S, Halyard, Michele Y, Abertnethy, Amy P, Baas, Frank, Barsevick, Andrea M, Bartels, Meike, Boomsma, Dorret I, Chauhan, Cynthia, Dueck, Amylou C, Frost, Marlene H, Hall, Per, Klepstad, Pal, Martin, Nicholas G, Miaskowski, Christine, Mosing, Miriam, Movsas, Benjamin, van Noorden, Cornelis JF, Patrick, Donald L, Pedersen, Nancy L, Ropka, Mary E, Shi, Quiling, Shinozaki, Gen, Singh, Jasvinder A, Yang, Ping, and Zwinderman, Ailko H

Published
2009

21. Understanding and Overcoming the Challenges Related to Cardiovascular Trials Involving Patients with Kidney Disease

Author

Ishida, Julie H., primary, Chauhan, Cynthia, additional, Gillespie, Barbara, additional, Gruchalla, Ken, additional, McCullough, Peter A., additional, Quella, Susan, additional, Romero, Alain, additional, Rossignol, Patrick, additional, Wheeler, David C., additional, Malley, Meaghan A., additional, West, Melissa, additional, and Herzog, Charles A., additional

Published
2021
Full Text
View/download PDF

23. Improving the Design of Future PCI Trials for Stable Coronary Artery Disease: JACC State-of-the-Art Review

Author

Marquis-Gravel, Guillaume, Moliterno, David J., Francis, Darrel P., Jüni, Peter, Rosenberg, Yves D., Claessen, Bimmer E., Mentz, Robert J., Mehran, Roxana, Cutlip, Donald E., Chauhan, Cynthia, Quella, Susan, Zannad, Faiez, and Goodman, Shaun G.

Subjects
Percutaneous Coronary Intervention, Research Design, Humans, Coronary Artery Disease, Quality Improvement, Article, Randomized Controlled Trials as Topic
Abstract

The role of percutaneous coronary interventions in addition to medical therapy for patients with stable coronary artery disease continues to be debated in routine clinical practice, despite more than 2 decades of randomized controlled trials. The residual uncertainty arises from particular challenges facing revascularization trials. Which endpoint do doctors care about, and which do patients care about? Which participants should be enrolled? What background medical therapy should we use? When is placebo control relevant? In this paper, we discuss how these questions can be approached and examine the merits and disadvantages of possible options. Engaging multiple stakeholders, including patients, researchers, regulators, and funders, to ensure the design elements are methodologically valid and clinically meaningful should be an aspirational goal in the development of future trials.

Published
2020

24. Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update

Author

Loprinzi, Charles L., primary, Lacchetti, Christina, additional, Bleeker, Jonathan, additional, Cavaletti, Guido, additional, Chauhan, Cynthia, additional, Hertz, Daniel L., additional, Kelley, Mark R., additional, Lavino, Antoinette, additional, Lustberg, Maryam B., additional, Paice, Judith A., additional, Schneider, Bryan P., additional, Lavoie Smith, Ellen M., additional, Smith, Mary Lou, additional, Smith, Thomas J., additional, Wagner-Johnston, Nina, additional, and Hershman, Dawn L., additional

Published
2020
Full Text
View/download PDF

25. Improving the Design of Future PCI Trials for Stable Coronary Artery Disease

Author

Marquis-Gravel, Guillaume, primary, Moliterno, David J., additional, Francis, Darrel P., additional, Jüni, Peter, additional, Rosenberg, Yves D., additional, Claessen, Bimmer E., additional, Mentz, Robert J., additional, Mehran, Roxana, additional, Cutlip, Donald E., additional, Chauhan, Cynthia, additional, Quella, Susan, additional, Zannad, Faiez, additional, and Goodman, Shaun G., additional

Published
2020
Full Text
View/download PDF

27. Patient partnership in cardiovascular clinical trials.

Author

Zannad, Faiez, Chauhan, Cynthia, Gee, Patrick O, Hartshorne-Evans, Nick, Hernandez, Adrian F, Mann, Marilyn K, Martinez, Robin, and Mehran, Roxana

Subjects
CLINICAL trials, PATIENT participation, CARDIOVASCULAR development, NEW product development, MEDICAL research
Abstract

Patients are ultimately the end-users of medical therapies and need to be actively integrated as contributors and decision-makers in the process of product development throughout product lifecycles. This is increasingly being recognized by patients, investigators, regulators, payers, sponsors, and medical journals. However, cardiovascular research remains behind other fields in terms of the extent of patient involvement and awareness of clinical trials in cardiovascular research. True patient partnerships in cardiovascular therapeutic development may permit more rapid recognition of unmet needs, ensure alignment of product development priorities with patient priorities, improve efficiency of trials (e.g. recruitment), and ensure outcomes of value to patients are being measured in trials (e.g. quality of life). This paper reviews ongoing initiatives and remaining opportunities to accomplish contributive patient involvement in cardiovascular clinical research. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

29. Eligibility and Radiologic Assessment for Adjuvant Clinical Trials in Kidney Cancer

Author

Agrawal, Sundeep, primary, Haas, Naomi B., additional, Bagheri, Mohammadhadi, additional, Lane, Brian R., additional, Coleman, Jonathan, additional, Hammers, Hans, additional, Bratslavsky, Gennady, additional, Chauhan, Cynthia, additional, Kim, Lauren, additional, Krishnasamy, Venkatesh P., additional, Marko, Jamie, additional, Maher, Virginia Ellen, additional, Ibrahim, Amna, additional, Cross, Frank, additional, Liu, Ke, additional, Beaver, Julia A., additional, Pazdur, Richard, additional, Blumenthal, Gideon M., additional, Singh, Harpreet, additional, Plimack, Elizabeth R., additional, Choueiri, Toni K., additional, Uzzo, Robert, additional, and Apolo, Andrea B., additional

Published
2020
Full Text
View/download PDF

30. Pragmatic randomised clinical trial of proton versus photon therapy for patients with non-metastatic breast cancer: the Radiotherapy Comparative Effectiveness (RadComp) Consortium trial protocol

Author

Bekelman, Justin E, primary, Lu, Hien, additional, Pugh, Stephanie, additional, Baker, Kaysee, additional, Berg, Christine D, additional, de Gonzalez, Amy Berrington, additional, Braunstein, Lior Z, additional, Bosch, Walter, additional, Chauhan, Cynthia, additional, Ellenberg, Susan, additional, Fang, L Christine, additional, Freedman, Gary M, additional, Hahn, Elizabeth A, additional, Haffty, B G, additional, Khan, Atif J, additional, Jimenez, Rachel B, additional, Kesslering, Christy, additional, Ky, Bonnie, additional, Lee, Choonsik, additional, Lu, Hsiao-Ming, additional, Mishra, Mark V, additional, Mullins, C Daniel, additional, Mutter, Robert W, additional, Nagda, Suneel, additional, Pankuch, Mark, additional, Powell, Simon N, additional, Prior, Fred W, additional, Schupak, Karen, additional, Taghian, Alphonse G, additional, Wilkinson, J Ben, additional, MacDonald, Shannon M, additional, and Cahlon, Oren, additional

Published
2019
Full Text
View/download PDF

39. Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline

Author

Hershman, Dawn L., primary, Lacchetti, Christina, additional, Dworkin, Robert H., additional, Lavoie Smith, Ellen M., additional, Bleeker, Jonathan, additional, Cavaletti, Guido, additional, Chauhan, Cynthia, additional, Gavin, Patrick, additional, Lavino, Antoinette, additional, Lustberg, Maryam B., additional, Paice, Judith, additional, Schneider, Bryan, additional, Smith, Mary Lou, additional, Smith, Tom, additional, Terstriep, Shelby, additional, Wagner-Johnston, Nina, additional, Bak, Kate, additional, and Loprinzi, Charles L., additional

Published
2014
Full Text
View/download PDF

40. Recommendations for Incorporating Patient-Reported Outcomes Into Clinical Comparative Effectiveness Research in Adult Oncology

Author

Basch, Ethan, primary, Abernethy, Amy P., additional, Mullins, C. Daniel, additional, Reeve, Bryce B., additional, Smith, Mary Lou, additional, Coons, Stephen Joel, additional, Sloan, Jeff, additional, Wenzel, Keith, additional, Chauhan, Cynthia, additional, Eppard, Wayland, additional, Frank, Elizabeth S., additional, Lipscomb, Joseph, additional, Raymond, Stephen A., additional, Spencer, Merianne, additional, and Tunis, Sean, additional

Published
2012
Full Text
View/download PDF

46. Letters.

Author

Embury, Declan, Kagan-Fleming, Dawn, Eastwood, Alexander, and Chauhan, Cynthia

Subjects
CREDIT ratings, NUCLEAR disarmament
Published
2022

47. Advancing Research on the Complex Interrelations Between Atrial Fibrillation and Heart Failure

Author

Al-Khatib, Sana M., Benjamin, Emelia J., Albert, Christine M., Alonso, Alvaro, Chauhan, Cynthia, Chen, Peng-Sheng, Curtis, Anne B., Desvigne-Nickens, Patrice, Ho, Jennifer E., Lam, Carolyn S.P., Link, Mark S., Patton, Kristen K., Redfield, Margaret M., Rienstra, Michiel, Rosenberg, Yves, Schnabel, Renate, Spertus, John A., Stevenson, Lynne Warner, Hills, Mellanie True, Voors, Adriaan A., Cooper, Lawton S., and Go, Alan S.

Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results